Archives | Trends in Biomaterials & Artificial Organs

Vol.. 34, No. S2 (2020)
COVID-19 Special Issue S2

COVID-19 Special Issue S2

More than 16 million cases of COVID-19 have now been reported by the World Health Organisation (WHO) with almost 620 thousand deaths. Almost all countries are affected by this pandemic, but half of the cases reported are from just three countries, namely the United States, Brazil and India. The pandemic has disrupted the lives of billions of people. Many have been at home for months. It is good news that Oxford-Astrazeneca COVID-19 vaccine has entered phase III clinical trials and the vaccine is reported to elicit a strong immune response in the host bodies and gave encouraging results. Human clinical trials for an indigenously developed vaccine for Covid-19 have been initiated in the country with approximately 1,000 volunteers participating in the exercise. The Drugs Controller General of India (DCGI) has permitted two vaccines - one developed by Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research and another one by Zydas Cadila Healthcare Ltd to go in for the first and second phase of human clinical trials. According to the WHO Director-General, “health is a human right, not a privilege”. The whole world is now looking optimistically at the scientific fraternity for the possible solutions to handle the grave situation. We have to play our own part in protecting ourselves. We are publishing our second issue on COVID-19 research.

The invitation by Trends in Biomaterials and Artificial Organs (TIBAO) for submitting COVID-19 research is still open. Reviews and articles which reports the developments in biomaterials, medical devices, tissue engineering and biomedicine specific to the management and control of COVID-19. This will be published in continuation of this second issue after rapid peer-review process.

Published: Jul 25, 2020

Vol.. 34, No. S1 (2020)
COVID-19 Special Issue S1

COVID-19 Special Issue S1

Mankind is going through an unprecedented phase of health disaster posed by the new corona virus pandemic. Society for Biomaterials and Artificial Organs India (SBAOI) express deep anguish towards the loss of lives, disruption of social life and the imminent economic crisis in the global scenario due to COVID-19. The whole world is looking optimistically at the scientific fraternity for the possible solutions to handle the grave situation. A lot of institutes and research groups worldwide have entered into intensive research on the management and control of COVID-19, despite the limitations of the crisis situation. Most of the research labs in the area of biomaterials and devices have entered in supporting research activities and are coming up with remarkable innovations.

SBAOI understands this is the time when the dissemination of knowledge and coordination of research outcomes are most required than ever. Therefore, we dedicate this issue of Trends in Biomaterials and Artificial Organs (TIBAO) for COVID-19 related research, particularly in the area of biomaterials, medical devices and tissue engineering. Manuscripts were peer-reviewed, copyedited, and produced on a war footing to get the manuscripts published on priority.

The invitation is open for reviews and articles which reports the developments in biomaterials, medical devices, tissue engineering and biomedicine specific to the management and control of COVID-19. This will be published in continuation of this issue after rapid peer-review process.

Published: May 31, 2020